Within the framework of the pharmaceutical quality support according to GMP requirements, the Farmak Company has successfully underwent an audit by the Medical Support and Equipment Department of the Ministry of Health of the Kyrgyz Republic and the National Center for Expert Examination of Medicines, Medical Devices and Equipment of the Ministry of Health of the Republic of Kazakhstan.
Inspectors of the Ministry of Health of the Kyrgyz Republic visited the plant on February 21-23, 2017 in order to analyze the state of production and quality control system of JSC Farmak.
On March 01-03, 2017, JSC Farmak passed the audit by the National Center for Expert Examination of Medicines, Medical Devices and Equipment of the Ministry of Health of the Republic of Kazakhstan to assess the production conditions and quality control system for compliance with GMP.
Inspectors appreciated the quality control system and logistics of JSC Farmak.
When buying Corvalol, consumers mean a drug under the brand of Farmak, which has been produced at the plant since 1959. This conclusion was made by International Marketing Group during its study of the level of consumer awareness of the drug marked “CORVALOL”. Most of the respondents surveyed noted that the drug called “Corvalol” is […]
As part of the celebration of the 60th anniversary of the first release of Corvalol manufactured by Farmak, leader of the Ukrainian pharmaceutical market, the Ukrainian Book of Records has recognized Corvalol by Farmak as the most known sedative in Ukraine. Corvalol by Farmak is a globally known medicinal product that has already become a […]
On Sunday, February 24, the final matches within UFAM League 3rd season (Kyiv Open Futsal Championship among health care institutions) took place. The tournament which started at the end of 2018 was ended with the great sport and health event. 12 teams participated in the competition this year, including the players from the Cardiology Institute, Kyiv [&hell...